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Predicting Functional Gains in a Stroke Trial
Steven C. Cramer, MD; Todd B. Parrish, PhD; Robert M. Levy, MD, PhD; Glenn T. Stebbins, PhD;
Sean D. Ruland, DO; David W. Lowry, MD; Theodore P. Trouard, PhD; Scott W. Squire;
Martin E. Weinand, MD; Cary R. Savage, PhD; Steven B. Wilkinson, MD;
Jenifer Juranek, PhD; Szu-Yun Leu, PhD; David M. Himes, BS
Background and Purpose—A number of therapies in development for patients with central nervous system injury aim to
reduce disability by improving function of surviving brain elements rather than by salvaging tissue. The current study
tested the hypothesis that, after adjusting for a number of clinical assessments, a measure of brain function at baseline
would improve prediction of behavioral gains after treatment.
Methods—Twenty-four patients with chronic stroke underwent baseline clinical and functional MRI assessments, received
6 weeks of rehabilitation therapy with or without investigational motor cortex stimulation, and then had repeat
assessments. Thirteen baseline clinical/radiological measures were evaluated for ability to predict subsequent
trial-related gains.
Results—Across all patients, bivariate analyses found that greater trial-related functional gains were predicted by (1)
smaller infarct volume, (2) greater baseline clinical status, and (3) lower degree of activation in stroke-affected motor
cortex on baseline functional MRI. When these 3 variables were further assessed using multivariate linear regression
modeling, only lower motor cortex activation and greater clinical status at baseline remained significant predictors. Note
that lower baseline motor cortex activation was also associated with larger increases in motor cortex activation after
treatment.
Conclusions—Lower motor cortex activity at baseline predicted greater behavioral gains after therapy, even after
controlling for a number of clinical assessments. The boosts in cortical activity that paralleled behavioral gains suggest
that in some patients, low baseline cortical activity represents underuse of surviving cortical resources. A measure of
brain function might be important for optimal clinical decision-making in the context of a restorative intervention.
(Stroke. 2007;38:2108-2114.)
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Stroke remains the leading cause of adult disability in theUnited States and many other countries1 with motor
deficits being among the most common contributors to this.2
Advances in acute stroke therapy have identified interven-
tions that can reduce infarct size and improve patient out-
comes.3 In parallel, a range of therapeutic approaches4–6 is
under investigation targeting the time period beyond the
initial poststroke hours. These restorative interventions aim to
improve outcome not by salvaging injured tissue, but rather
by promoting repair and favorably modifying function within
surviving brain areas.
Clinical stroke trials aim to enroll those most likely to
respond to therapy. Predicting the population that will have
optimal response to therapy is a complex challenge.7–10 Entry
criteria often approach this goal by using clinical measures
such as time after injury, age, and severity of baseline
behavioral deficit. Such measures are high in accessibility but
often only approximate the physiological state of the tissue
target.11 A more direct measure of the brain biological target
would likely improve the ability to selectively enroll patients
with high likelihood of therapeutic benefit, particularly be-
cause a wide range of brain events and behavioral strategies
can produce the same behavioral phenotype. This approach
has received increased attention in the acute stroke set-
ting,3,12,13 in which measurement of brain injury and perfu-
sion have proven instructive. In the setting of chronic stroke,
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when an intervention is restorative, a measure of functional
neuroimaging might have similar use for at least 2 reasons.
First, for an intervention that improves behavior by changing
brain function, a baseline measure of brain function within
the behavioral system of interest might be informative as to
likelihood of achieving gains in the behavior of interest.
Second, in some settings,14–17 human brain mapping provides
insights into neurologically relevant brain events that are not
available from behavioral examination or anatomical
imaging.
The current study examined this possibility by addressing
the hypothesis that after adjusting for other baseline variables,
a lower degree of activation in the motor cortex at baseline
predicts both larger motor gains as well as larger increases in
motor cortex activity from subsequent therapy. Degree of
motor cortex activation refers to the change in functional
MRI (fMRI) signal between rest and motor task performance.
As a corollary, other measures of motor cortex activation,
including site and volume, were also analyzed. These hypoth-
eses were motivated in part by prior observations that
therapies that improve motor function in the chronic stroke
setting have been associated with an increase in several
measures of motor cortex activation.18 Other predictive base-
line variables evaluated in the current study along with fMRI
measures of motor cortex function included established pre-
dictors of spontaneous behavioral recovery after stroke7,8
such as subject age, time poststroke, baseline deficits, and
infarct volume. Degree of motor cortex activation was mea-
sured through an fMRI scan during performance of a motor
task by the affected arm obtained before therapy initiation.
Prediction of behavioral gains was evaluated in the context of
a clinical trial of 6 weeks of rehabilitation therapy with versus
without simultaneous motor cortex stimulation.
Methods
Subjects and Clinical Trial Design
At each of 7 US medical centers, patients with a chronic ischemic
stroke and moderate arm paresis were evaluated for enrollment in an
unblind, prospective, randomized study to evaluate subthreshold
motor cortex electrical stimulation arm motor deficits. Enrollment
consisted of consent in accordance with local Institutional Review
Boards, screening, and baseline clinical and MRI assessments,
including arm motor Fugl-Meyer (FM) score. The arm motor FM
score19,20 evaluates 33 features of arm motor behavior and was a
study primary outcome measure. Scores on the arm motor FM score
range from 0 to 66 with higher scores representing superior function.
Patients meeting entry criteria and having an interpretable fMRI scan
showing ipsilesional motor cortex activation and then received 6
weeks of therapy with randomization to either no cortical stimulation
or concurrent cortical stimulation from an implanted investigational
cortical stimulation device system (Northstar Neuroscience). The
MRI scan was repeated within 2 weeks and the arm motor FM score
reassessed within 4 weeks after completing rehabilitation therapy.
Enrollees were required to have ischemic stroke that was at least
4 months previously; arm motor FM score between 20 to 50 points;
active wrist extension of at least 5°; age 21 years; no history of
seizure; and no substantial neglect, depression, or sensory deficit.21
Any patient started in the prior 2 months on a medication that could
potentially confound a study of stroke recovery such as amphet-
amine, antiepileptics, anxiolytics, or antidepressants was excluded. A
total of 38 patients were enrolled across 7 centers to obtain 24
eligible patients at 5 centers.
The study timeline (Figure 1) started with baseline assessments,
which included demographic data, fMRI scanning, and arm motor
FM score. Participants with scans free of artifact were then random-
ized as described previously.
All patients then received 6 weeks of rehabilitation therapy that
targeted arm motor function, especially distally. The therapy pro-
gram consisted of task-oriented training of goal-directed movements.
Strategies for reaching, grasping, lifting, and manipulating objects
were emphasized as were self-care and activities of daily living.
Proximal arm strengthening and range of motion were also incorpo-
rated. The program included 4 weeks (5 days per week) of this
therapy in all cases. In the first 7 subjects, this was followed by 2
additional weeks (3 days/weeks) of this program therapy, and for the
remainder, this was preceded by 2 weeks of rehabilitation precondi-
tioning. Each session lasted approximately 2.5 hours.
For patients randomized to therapy plus cortical stimulation, the
most significantly activated voxel on the posterior half of the
precentral gyrus of the stroke-affected hemisphere was identified and
used to guide placement of the epidural electrode. This electrode was
connected to a stimulator that was switched on during therapy. The
electrode was removed on completion of the 6 weeks of rehabilita-
tion therapy.
Functional MRI Scanning
At each site, before therapy, each patient underwent fMRI that
alternated 20 seconds rest with 20 seconds of motor task performed
by the paretic hand. These rest/task cycles were repeated for a total
of 300 brain volumes. The task performed was index finger tapping
when possible, wrist extension, or squeezing (gently on a tennis ball)
at 0.25 Hz in all cases. Before scanning, each patient was trained to
move approximately 5° entrained by an auditory metronome.
Each site imaged with standardized parameters: time to repeti-
tion2000 ms, echo time50 ms, in-plane resolution3.75
3.75 mm, and field of view that included cerebral vertex to Sylvian
fissure through 5-mm axial slices with interslice gap0 mm. A
volumetric T1-weighted anatomical image (slice thickness 1 to
2 mm) was also acquired during this session. At 3 sites, data were
acquired with a 3.0-T Siemens scanner; at one site, a 3.0-T General
Electric scanner; and at one site, a General Electric 1.5-T scanner.
Each subject returned to the same scanner for repeat MRI with the
same activation task at the same movement rate approximately 2
weeks after the end of therapy.
Image Analysis
Images were processed at each site using an automated script run
with MEDx software (Sensor Systems). Motion correction and
in-plane spatial smoothing (6-mm full-width half-maximum) were
followed by linear detrending and generation of Z-maps contrasting
Figure 1. Study timeline.
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blocks of movement with rest. At one of the author’s laboratories
(S.C.C.), infarct volume was determined from the volumetric ana-
tomical images using semiautomated methods, which consisted of
using thresholds to estimate an infarct mask and then refining this by
hand to achieve final values. Motor cortex activation volume was
determined by measuring the volume of the largest activation cluster
on the posterior precentral gyrus of the stroke-affected hemisphere
thresholded at Z 3. Motor cortex activation site was determined by
identifying the Talairach coordinates (x, y, z) for the most signifi-
cantly activated voxel within this cluster. Degree of motor cortex
activation represents percent change in MRI signal between rest and
movement and was measured as the mean across all voxels in 5
motor cortex regions of interest on each subject’s activation map.
Note that even when an ipsilesional motor cortex activation cluster is
clearly present, mean degree of activation can be positive or negative
because of the large number of voxels in a region of interest. The
main region of interest was the hand area of ipsilesional primary
motor cortex, which was defined in 3 different ways. The first
method, which was used in the primary statistical analyses, used a
region of interest weighted according to meta-analysis of prior
imaging studies (http://hendrix.imm.dtu.dk/services/jerne/ninf/
voi.html) as represented in Talairach stereotaxic space. Two second-
ary analyses defined hand area differently to test the robustness of
degree of activation in ipsilesional primary motor cortex. One
approach used a 12-mm sphere centered about the middle of this
same region of interest with all voxels weighted the same. A third
approach used a 12-mm sphere centered about the motor cortex
activation site as defined for each individual subject. The other 4
regions were the contralesional primary motor cortex using the same
meta-analysis region as previously mentioned but in the opposite
hemisphere; a 12-mm sphere centered around premotor cortex
coordinates in each hemisphere, also determined from the previously
mentioned url; and a 12-mm sphere centered around the supplemen-
tary area as defined by the previously mentioned url.
Statistics
The primary outcome measure that was evaluated, change in arm
motor FM score, was determined from the first pretherapy assess-
ment to 4 weeks after the end of rehabilitation treatment. Thirteen
baseline predictive variables were evaluated, including established7,8
predictors of outcome after stroke (baseline clinical status measured
here as arm motor FM score, age, time poststroke, and infarct
volume) and measures of brain activation related to the study
hypothesis (fMRI motor cortex activation volume; activation site
with x-, y-, and z-coordinates treated separately; and degree of
activation in each of the 5 motor cortices). Attempts were made to
transform nonnormally distributed variables whenever possible; this
could be accomplished for infarct volume (through natural log
transform) and for activation volume (through square root trans-
form). For comparison of baseline measurements, a 2-sample t test
was used for normally distributed measurements, which were all
except activation site x, y, and z plus degree of activation; these 4
were both nonnormally distributed and therefore evaluated with the
Wilcoxon rank test.
Bivariate analysis was performed to evaluate the linear relation-
ship between each potential predictive variable, measured at base-
line, and the outcome variable using Pearson correlation for normally
distributed measurements and Spearman rank ordered correlation for
nonnormally distributed measurements. Next, a multivariate linear
regression model using forward stepwise selection (probability to
remain in the model of P0.15) determined which baseline predic-
tive variables have a significant effect on predicting the change in
arm motor FM score. The residuals of the regression model were
examined for normality assumption. Partial correlation coefficients
were also determined. All analyses were done using SAS 9 and
JMP-5 with a significance level of 0.05 for 2-sided testing.
Results
A total of 24 patients met all entry criteria and were
randomized, 15 male and 9 female, 21 right-handed and 3
left-handed, with stroke affecting the dominant side in 13 and
nondominant in 11. Stroke topography was subcortical in 12,
cortical in 3, both in 8, and pontine in one. The motor task
during fMRI was index finger tapping for 4, wrist extension
for 17, and squeezing for 3. Investigator assessment of motor
task performance during fMRI indicated 21 subjects with
accurate performance and 3 subjects with reduced but present
movements.
Baseline values for predictive variables are presented in
Table 1. None was significantly different (P0.14 to
P0.91) between the 2 treatment arms. The outcome
variable, change in arm motor FM scores from baseline to
4 weeks after the end of therapy, showed an overall
increase of 4.14.8 (meanSD; range, 3 to 17) points
with patients receiving rehabilitation therapystimulation
improving 5.84.7 points and patients receiving rehabili-
tation therapy alone improving 2.54.5 points. These arm
motor FM changes differ slightly from those reported
elsewhere, because the current analysis used a single
baseline measure for all predictive variables, including
arm motor FM scores, whereas the other analysis used the
average of 2 baseline arm motor FM scores (Huang M,
unpublished data). Direct comparison of the 2 groups by t
test did not disclose a significant difference in gains
(P0.097), but, as described elsewhere (Huang M, unpub-
lished data), repeated-measures analysis of variance mod-
eling using the GENMOD procedure in SAS found signif-
icantly greater gains with stimulation during the entire
follow-up period from 4 to 24 weeks posttherapy
(P0.042). Of the 24 patients, 18 showed a gain in arm
motor FM score, 11 of 12 in the rehabilitationstimulation
TABLE 1. Predictive Variables: Distribution and Correlation
With Outcome Measure
Predictive Variable MeanSD
Correlation
With Change
in Arm Motor
FM Score
P Value
for
Correlation
Baseline arm FM motor score 32.48.3 0.47 0.02
Age, years 57.613.9 0.16 0.47
Time poststroke, months 33.123.3 0.14 0.51
Stroke volume, cc 54.0143 0.48 0.02
Activation volume, mm3 91768663 0.03 0.89
Activation location—x 31.55.7 0.08 0.73
Activation location—y 25.78.1 0.12 0.57
Activation location—z 50.75.5 0.006 0.98
Degree of activation
Ipsilesional motor cortex 0.470.59 0.45 0.03
Contralesional motor cortex 0.450.60 0.21 0.33
Ipsilesional premotor cortex 0.490.47 0.02 0.93
Contralesional premotor
cortex
0.350.34 0.13 0.55
Supplementary motor area 0.580.49 0.26 0.21
For each of the 13 predictive variables, the distribution (column 2) and
bivariate correlation with the outcome measure (columns 3 to 4) are presented.
P values are not corrected for multiple comparisons. Data are for all 24
patients.
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group, and 7 of 12 in the rehabilitation therapy alone
group.
Bivariate analyses (Table 1) for the 13 predictive variables
found that 3 had a significant relationship with the change in
arm motor FM score (0.01 P0.05). These 3 were retained
in the stepwise multivariate linear regression model.
The multivariate model (Table 2; Figure 2A, B) found that
2 of the 3 variables evaluated had significant predictive value.
Specifically, a lower degree of activation in ipsilesional
primary motor cortex and higher arm motor FM score
predicted a higher change in arm motor FM score during the
study. That each of these 2 factors contributed to the
predictive ability of the model is supported by the partial
correlation coefficients that each had with change in arm
motor FM score (r0.48 for degree of activation in
ipsilesional primary motor cortex and r0.46 for baseline
arm motor FM score). Degree of ipsilesional primary motor
cortex activation was a solid predictor, because when either
of the secondary definitions of this measure was used instead,
degree of ipsilesional primary motor cortex activation be-
came the only significant variable surviving the model.
Other variables of potential interest did not influence
model results. Each of the following variables of interest,
when added to the model, was not significant and did not
change model results: treatment arm assignment, side of
TABLE 2. Multivariate Analysis
Parameter Estimate 95% CI P t 
Baseline arm motor FM score 0.24 0.04–0.044 0.024
Degree of activation in ipsilesional
primary motor cortex
3.54 6.26–0.82 0.019
The overall model r20.40. Residuals of the multivariate model were
normally distributed.
Figure 2. Three measures that are related to behavioral gains during clinical trial participation. A measure of baseline motor status (arm
motor FM score, A) and of baseline brain function (degree of activation in ipsilesional primary motor cortex, measured from fMRI brain
mapping, B) each predict behavioral gains from subsequent therapy. These behavioral gains were paralleled by an increase in degree
of ipsilesional primary motor cortex activation on fMRI scanning (C). Furthermore, those subjects with the smallest degree of ipsile-
sional primary motor cortex activation at baseline had the biggest changes in this measure after treatment (D). Thus, those subjects
with the smallest degree of activation at baseline had the biggest clinical gains in parallel with the largest increases in cortical activity
over time. Squares indicate wrist extension used as the motor task during fMRI; circles, grasping; and rectangles, index finger tapping.
Solid symbols are data acquired at 3-T MRI; hollow symbols, at 1.5 T. A slash indicates subjects in the therapystimulation group; no
slash, rehabilitation therapy alone group.
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stroke, topography of stroke, enrollment site, and fMRI
activation task. Degree of ipsilesional primary motor cortex
activation (P0.005), but not volume or site, differed signif-
icantly in relation to MRI field strength, but the level of motor
deficits were evenly distributed across the 2 different scanner
field strengths (P0.4). Degree of activation in ipsilesional
primary motor cortex did not differ across fMRI motor tasks.
Restricting data analysis to only the 17 of 24 subjects who
performed wrist extension during fMRI had no effect on the
multivariate analysis (Table 2) with trivial changes in the
estimate and no change in the probability values.
On repeat fMRI scanning (n20), the change in degree of
activation over time within the ipsilesional primary motor
cortex correlated with change in arm motor FM score
(r0.46, P0.05; Figure 2C). Also, the change in degree of
activation over time within the ipsilesional primary motor
cortex was inversely related to the degree of ipsilesional
primary motor cortex activation at baseline (r0.59,
P0.007; Figure 2D). Overall, there was no significant
change over time in degree of activation within ipsilesional
primary motor cortex, ie, the average degree of activation at
baseline was not significantly different than the average
degree of activation posttherapy (0.470.59 versus
0.470.52, P0.9). Also, the degree of ipsilesional primary
motor cortex activation was not significantly different be-
tween the 2 treatment groups at either time point. Note too
that the degree of ipsilesional primary motor cortex activation
at either of the 2 fMRI scans did not correlate with baseline
arm motor FM score (P0.5). Of the 20 subjects able to
undergo repeat fMRI scanning, 18 performed the same motor
task at both fMRI scans, whereas the task was different in 2;
removal of the latter 2 had no effect on results.
The presence of carotid disease was examined because of
its potential effects on fMRI results. Seventy percent or
greater internal carotid artery stenosis was present on the side
of the infarct in 4 patients. The 4 patients with internal carotid
artery disease on the side of the infarct, as compared with the
20 who did not, had larger infarct volumes (226307 versus
2047 mL, P0.05) and greater deficits (baseline arm motor
FM score (234 versus 348, P0.005). However, carotid
narrowing was not associated with differences in any of the
other predictive variables, including the fMRI measures.
Discussion
The current study found that degree of behavioral improve-
ment over 6 weeks of participation in this restorative stroke
study was predicted by 2 baseline measures, arm motor
function and degree of ipsilesional primary motor cortex
activation during affected hand movement. To our knowl-
edge, this is the first demonstration that predicting treatment-
related gains in a clinical trial setting can be improved by
measuring baseline brain function. Predicting behavioral
gains in a restorative stroke trial might therefore be most
accurately achieved by including a baseline measure of brain
function along with clinical assessments.
The degree of ipsilesional primary motor cortex activation
during affected hand movement was a significant predictor of
behavioral gains during the trial (Table 2; Figure 2). Subjects
with smaller baseline cortical activity had larger behavioral
gains (Figure 2B) and larger increases in cortical activity
(Figure 2D) after therapy, whereas subjects with larger
baseline cortical activity had poorer behavioral gains with
less boosts in cortical activity over time. One interpretation of
this constellation of findings is that subjects with the highest
level of baseline cortical activity were already operating in a
state of maximum output with no reserve remaining to boost
either cortical activity or behavioral output in response to
treatment. Subjects with lower baseline primary motor cortex
activity were a mixed population. Some were able to increase
activity in parallel with gains in behavioral status, possibly
indicating learned nonuse22 of an available and modifiable
substrate at baseline. Others were in a different state and not
able to increase either behavior or cortical activity. Future
studies can address a corollary hypothesis that the latter
subgroup can be prospectively distinguished on the basis of
reduced neurophysiological23,24 and/or radiological25 mea-
sures of corticospinal tract integrity.
Degree of ipsilesional primary motor cortex activation
predicted trial-related gains, but volume and site of activa-
tion, which often change after stroke,26 did not (Table 1). One
possible reason for this constellation of findings is that degree
of activation might have the most direct relationship to the
neuronal events most important to achieving treatment-
related behavioral gains given its relationship to neuronal and
synaptic activity.27–30 Degree of activation had a predictive
value in the ipsilesional primary motor cortex, but not within
the secondary and contralesional motor regions examined,
attesting to the critical importance of the primary motor
cortex in the genesis of voluntary motor behavior.
The current findings were derived by combining subjects
in the 2 treatment groups. Whereas the repeated-measures
modeling used to analyze the full clinical trial found an
outcome difference among the 2 treatment groups (Huang M,
unpublished data), the difference between treatment groups in
a measure of clinical status at one time point posttherapy did
not reach significance, and a factor representing treatment
arm assignment was not significant when added to the model
and did not change model results.
Several studies have examined the effect of a restorative
intervention on brain function in humans.31–39 In general,
interventions that improve motor behavior in the setting of
chronic stroke are associated with parallel increases in activity of
sensorimotor cortices either ipsilesionally or bilaterally.18 A
smaller number of studies have used assessment of brain
function to predict response to a restorative intervention.40–43
For example, Koski et al,43 using transcranial magnetic
stimulation, and Dong et al,41 using fMRI, have found that
changes in brain function early into therapy anticipate final
behavioral gains. The current study extends these efforts in 2
main ways. First, prediction was assessed from a single
baseline assessment. Second, multivariate linear regression
modeling was used to confirm that an assessment of brain
function has predictive value after controlling for other
baseline measures, many of which are known to predict
outcome in spontaneous stroke recovery.
Baseline clinical status was a second measure indepen-
dently associated with greater gains from therapy. Such
clinical measures are known to have predictive value for
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response to rehabilitation therapy,7–9 but alone do not com-
pletely predict treatment-related gains. The current results
suggest that adding a measure of brain function to clinical
assessments improves ability to predict behavioral gains after
restorative therapy. The current study used fMRI for this
measure, but a range of brain mapping methods, including
some easier to use in the study of patients with stroke,23,44–46
might have similar predictive value.
The multivariate model (Table 2) accounted for 40% of
variance in the outcome measure. Other sources of variance
included lesion side, MRI field strength, therapeutic interven-
tion, fMRI activation task, as well as intersubject differences
in the many other variables that modify brain function after
stroke.47 These might have also contributed to the limited
relationship observed between arm motor FM score and fMRI
measures at baseline, although enrollment of patients with
deficits spanning a relatively wide range might also underlie
this finding. However, despite these sources of variability,
degree of activation within the ipsilesional motor cortex at
baseline was one of the primary predictors of therapy-related
behavioral gains, remaining significant when several different
approaches were used.
In conclusion, both clinical assessments and a measure of
brain function are useful to best predict behavioral gains from
restorative therapies. Future studies might evaluate the cur-
rent findings in the setting of other restorative therapies or
examine the use of a baseline measure of brain function to
serve as an entry criterion or to guide dose of a restorative
intervention. As restorative therapeutic approaches4 continue
to advance through clinical trials, measures of brain function
will likely prove useful as an adjunct to clinical assessments.
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